CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Agennix AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Agennix AG
Landsbergerstrasse 302
Phone: +49 8990405464p:+49 8990405464 Munich, 80687  Germany Fax: +49 8990405811f:+49 8990405811

This company is no longer actively traded on any major stock exchange.

Business Summary
Agennix AG is a Germany-based biopharmaceutical company. The Company focuses on the development of therapies, which improve the lives of critically ill patients in areas of major unmet medical need. The Company is focused on pharmaceutical companies and biotechnology firms with presence in the area of critical care and/or cancer development and commercialization. The Company’s investigational agents include oral talactoferrin; a topical gel formulation of talactoferrin for treating chronic wounds, and RGB-286638, a multi-targeted kinase inhibitor in Phase I testing for cancer. The Company’s site of operation is in Princeton, New Jersey.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201212/31/2011Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board ChristofHettich 11/1/2009 11/1/2009
Spokesperson of the Management Board, Chief Financial Officer TorstenHombeck 3/1/2011 11/1/2009
Vice Chairman of the Supervisory Board Frank E.Young 85 11/1/2009 11/1/2009
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Agennix, Inc. 101 College Road East Princeton NJ United States

Business Names
Business Name
Agennix AG
Agennix Incorporated
AGX
GAGXF
GPC Biotech AG

General Information
Outstanding Shares: 51,270,258 (As of 9/30/2012)
Stock Exchange: FRA
Fax Number: +49 8990405811


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023